Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b, Double-Blind, Randomized, Placebo-Controlled Study of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)

NCT02669433 is registered in ClinicalTrials.gov with Axovant Sciences Ltd. as lead sponsor.

NCT NCT02669433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02669433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b, Double-Blind, Randomized, Placebo-Controlled Study of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Lead sponsor
Axovant Sciences Ltd.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2016
Completion date
December 31, 2017
Enrollment
484 (actual)
Sites
65

Conditions

As the registry lists them; a condition with its own page is linked.

dementia with lewy bodies